cbst

Cubist Presents Detailed Results from Positive Phase 3 Trials of Ceftolozane/Tazobactam at 2014 European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

[Business Wire] – Cubist Pharmaceuticals, Inc. today announced the first detailed results from positive pivotal Phase 3 clinical trials of its antibiotic candidate ceftolozane/tazobactam in development to treat serious infections including complicated ur moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

CUBIST PHARMACEUTICALS INC Financials

moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of One Lot of CUBICIN (daptomycin for injection) 500 mg in 10 mL single use vials Due to Presence of Particulate Matter

[Business Wire] – Cubist Pharmaceuticals, Inc. today announced it is voluntarily recalling one lot of CUBICIN® to the user level due to the presence of part moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

1:52 pm Cubist Pharma: FDA advisory committee unanimously recommends approval of Cubist’s SIVEXTRO as treatment for serious skin infections

moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

U.S. FDA panel votes in favor of two anti-infective drugs

[Reuters] – A panel of advisers to the U.S. Food and Drug Administration gave favorable reviews on Monday to two new medications to treat acute bacterial skin infections. The panel voted unanimously that Cubist Pharmaceuticals Inc’s tedizolid and Durata moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is […]

[$$] Raiding Fannie and Freddie

[at The Wall Street Journal] – Apple and Samsung are squaring off this week in a new round of their long-running patent feud. This time, however, the docket might as well read Apple v. Google moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to […]

[$$] Regulators Twice Failed to Open GM Probes

[at The Wall Street Journal] – Telecom providers want to end the era of copper-wire landlines. moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]

3 Upcoming FDA Meetings You Should be Watching

moreView todays social media effects on CBSTView the latest stocks trending across Twitter. Click to view dashboardSee who Cubist is hiring next, click here to view […]